Moderna Aktie
WKN DE: A2N9D9 / ISIN: US60770K1079
27.03.2024 12:01:35
|
Blackstone Invests $750 Mln In Moderna's Influenza Program
(RTTNews) - Wednesday, Blackstone Inc. (BX) announced a new partnership with Moderna, Inc. (MRNA) through a development and commercialization funding agreement, funds managed by Blackstone Life Sciences will provide up to $750 million to support Moderna's influenza program.
If successful, Blackstone Life Sciences may receive milestones and royalties from the resulting flu products.
Moderna will consider the funding as a deduction in research and development costs and will maintain complete ownership and oversight of the Company's influenza initiative.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Blackstonemehr Nachrichten
Analysen zu Moderna Incmehr Analysen
19.11.24 | Moderna Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.09.24 | Moderna Underweight | JP Morgan Chase & Co. | |
05.08.24 | Moderna Sector Perform | RBC Capital Markets | |
12.01.24 | Moderna Outperform | RBC Capital Markets | |
03.11.23 | Moderna Buy | Goldman Sachs Group Inc. |
Aktien in diesem Artikel
Blackstone | 149,80 | -0,01% |
|
Moderna Inc | 21,56 | 4,03% |
|